Cg Oncology, Inc.
CGON
Revenue
0.00
0.000.00%
-Assets
564.33M
▼-14.78M▼-2.55%
3 Months ChangeLiabilities
11.97M
▲1.80M▲17.73%
3 Months ChangeFree Cash Flow
-26.02M
▼-26.02M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-093238
2024-08-08
Form 8-K
ID: 0000950170-24-093237
2024-05-24
Form 8-K
ID: 0000950170-24-064309
2024-05-09
Form 8-K
ID: 0001193125-24-134805
2024-05-09
Form 10-Q
ID: 0000950170-24-056196
2024-05-03
Form 8-K
ID: 0001193125-24-130800
2024-02-16
Form 8-K
ID: 0001193125-24-038506
2024-01-30
Form 8-K
ID: 0001193125-24-018715